Method of filling a drug capsule and article produced thereby

Information

  • Patent Grant
  • 6280410
  • Patent Number
    6,280,410
  • Date Filed
    Friday, October 2, 1998
    25 years ago
  • Date Issued
    Tuesday, August 28, 2001
    23 years ago
Abstract
A needleless injector drug capsule assembly comprising a container, housing therefor, a piston, and resilient seals to permit filling and sealing thereafter to maintain sterility of the contents.
Description




FIELD OF THE INVENTION




Background of the Invention




This invention relates to a method of filling a disposable drug capsule for assembly to a needleless injector, and to an article produced thereby.




Needleless injectors are used as an alternative to hypodermic syringes to inject drugs through a patient's skin into the underlying tissues. A typical injector comprises a high pressure pump which dispenses a dose of liquid drug through a small hole with sufficient force to pierce the epidermis and diffuse into the tissues. This technique has been in use for over fifty years, and there are many patents covering various constructional details. A feature of practically all prior art injectors is that they are filled with drug by the user before injection: this has resulted in a number of inconvenient preparatory steps and the need to sterilize the drug chamber between each operation.




There has been a marked trend over the past twenty years to supply liquid drugs and other liquids for medical use pre-packed—for example, the familiar prefilled hypodermic syringe, or intravenous infusion bags containing a saline solution. Such presentation has several advantages: the stringent requirements for sterility are met by the manufacturer; the dosage is correct; separate vials of drug and separate syringes are not required; distribution of small quantities is facilitated; convenience and ease of use result in significant cost savings.




Needleless injectors have generally not taken advantage of these trends, and this has been a factor in the lack of widespread use of such devices. Whilst there have been attempts to use prefilled capsules, these have largely failed to address the problems and techniques associated with aseptic filling and maintaining sterility after filling. Thus, what appeared to be promising advances in the art were frustrated by the inability to aseptically fill at an economical price, and such inventions rarely progressed from laboratory prototypes.




SUMMARY OF THE INVENTION




According to the present invention there is provided a method of filling a needleless injector capsule with a drug in a liquid form, and sealing the capsule after filling, the capsule defining a chamber which communicates with the exterior prior to sealing, via an orifice in the capsule wall and an orifice in an adjacent seal held in a seal carrier, the method comprising:




(a) introducing liquid into the chamber via the seal orifice and the capsule orifice, and




(b) closing off the seal carrier to the exterior.




The invention further provides a filled and sealed drug-containing article, which comprises a needleless injector capsule defining a chamber having a drug in liquid form therein, the capsule having an orifice through a wall thereof, a seal carrier having therein a seal in which is formed an orifice communicating with the capsule orifice, and closing means for closing the seal carrier to the exterior whereby to seal off the drug in the chamber from the exterior.




A preferred embodiment comprises a hollow cylindrical capsule open at one end, and terminating in a fine hole which is the injection orifice to be placed upon the skin. A piston is slidingly and sealing located within the capsule bore adjacent to the orifice. The capsule is retained within a housing configured to connect to a needleless injector power source. Frangibly attached to the housing at the orifice end is a short tube which carries a resilient seal adapted to receive a filling needle. After filling, the filling needle is withdrawn, and a resilient plug is inserted into the short tube to form a sterile seal. During the filling process, the piston within the capsule is driven by the hydraulic pressure of the drug to some predetermined position with respect to the required fill volume. The filled capsule is then attached to the injector energy source. Before use, the frangibly connected tube is snapped off complete with the resilient seals, thus exposing the capsule orifice. The injector is then operated according to the required methodology.











BRIEF DESCRIPTION OF THE DRAWINGS




A detailed description follows, with reference to the accompanying drawings, all of which, except

FIG. 5



a,


are centre-line sectioned drawings. In the drawings:





FIG. 1

shows the capsule, housing and seal carrier assembled and empty;





FIG. 2

shows the filling needle inserted;





FIG. 3

shows the capsule filled and sealed;





FIG. 4

depicts the capsule attached to an injector energy source, and prepared for use;





FIG. 5

shows a filled and sealed capsule, sealed by an alternative sealing method;





FIG. 5



a


is an end view of what is shown in

FIG. 5

;





FIG. 6

shows a filled capsule sealed by another alternative sealing method;





FIG. 7

shows an alternate embodiment of the capsule, housing and seal carrier assembled and empty, with the sealed carrier attached to the capsule.











DETAILED DESCRIPTION OF THE INVENTION





FIG. 1

shows a capsule


2


in the form of a hollow cylindrical chamber having a small injection orifice


7


at one end and containing a resilient piston


3


located adjacent to the orifice


7


. As shown, the internal shape of the capsule


2


is preferably frusto-conical adjacent the orifice


7


to aid flow of the liquid during injection, and the piston is of a similar shape to reduce dead volume.




The assembly of capsule


2


and piston


3


is retained within a housing


1


, either by friction of by mechanical means. Housing


1


has a thread


12


or other means for attaching the assembly to a needleless injection power source. A seal carrier


8


, in the form of a short tube, is frangibly attached by a frangible connection


4


to the housing


1


, and contains a resilient seal


5


. The seal carrier


8


may also be attached directly to capsule


2


, as shown in FIG.


7


. Alternatively, the seal carrier


8


may be attached to housing


1


by snap fitting or other mechanical means. The resilient seal


5


has an aperture


6


therethrough which is in hydraulic connection with the orifices


7


in capsule


2


, and the cooperating faces of the capsule


2


and the seal


5


form an hydraulic seal.




Referring to

FIG. 2

, a filling needle


9


is inserted sealingly into the aperture


6


of seal


5


, and injectate


11


is forced under pressure through the orifice


7


into the capsule


2


. Hydraulic pressure forces the piston


3


along the bore of the capsule


2


to a predetermined position which represents the volume to be injected, after which the filling needle


9


is withdrawn. Filling needle


9


may have a stop


13


to control the depth of penetration of the filling needle


9


in the hole


6


of seal


5


. Stop


13


may also be a locational sliding fit within the bore of the seal carrier


8


to assist in guiding the needle


9


into aperture


6


.




After filling, a resilient plug


10


is inserted into the bore of the seal carrier


8


, as shown in FIG.


3


. Thus, the injectate


11


is sealed within the capsule by the resilient plug


10


, the resilient piston


3


, and the seal between the face of seal


5


and capsule


2


.




Preferably all the components except resilient plug


10


are supplied to the filler in a sterile condition and pre-assembled, but of course they may be supplied separately and sterilised prior to filling. The filling is preferably conducted under sterile conditions, so that any air trapped within the injectate


11


, or between seal


5


and plug


10


, is sterile. Alternatively, the completely filled assembly may be sterilized after filling by heat or radiation if appropriate.





FIG. 4

shows the filled capsule and housing attached to a needleless injector power source, and prepared for use by snapping off the seal carrier


8


together with seal


5


and plug


10


.




An alternative method of sealing the capsule after filling is shown in

FIGS. 5 and 5



a.


Seal carrier


8


is manufactured in a material which may be deformed, by the action of heat for example, and crimped together to form a seal as shown diagrammatically at


15


. The seal may be improved if the material is melted at the joint or coated with a suitable meltable sealant/adhesive. Other methods of effecting the seal include ultrasonic welding, friction welding, radiation-curing sealant, or a separate clamping component to hold the walls of seal carrier


8


in sealing contact. Thus the basic principle of sealing according to

FIG. 5

is to deform the seal carrier


8


so that the inner walls make and maintain sealing contact.




Another alternative sealing method is shown in FIG.


6


. Here, a plug


14


is sealingly inserted into the filling hole


6


of resilient seal


5


after filling.




The preferred material for the capsule is glass, and for the piston polytetrafluoroethylene (PTFE), but other combinations are suitable according to the intended application. Alternatively, the capsule may be made of the same material as the housing, and for convenience be manufactured as one component. The seal carrier is then directly attached to what is, in effect, the capsule itself. Yet another variation is for the housing to be moulded on to the capsule. In the case of a glass capsule, it is desirable to assemble it to, or mould it on, the housing soon after manufacture of the glass to prevent abrasive damage to the glass.




The procedures and components described permit a conventional syringe filling machine to be used with the minimum of modification. If small numbers of capsules are to be filled, then the filling needle


9


may be replaced by a conventional hypodermic syringe needle, and the drug may be dispensed from a syringe.




If it is required to reduce the volume of trapped air within the assembly, the air may be evacuated immediately prior to inserting the filling needle.



Claims
  • 1. A filled and sealed drug-containing article for attachment to a needleless injector power source, which comprises a needleless injector capsule defining a chamber having a drug in liquid form therein, the capsule having an orifice through a wall thereof, a seal carrier having therein a seal in which is formed an orifice communication with the capsule orifice, the seal being in sealing contact with the capsule wall around the orifice in the capsule wall, and closing means for closing the seal carrier to the exterior whereby to seal off the drug in the chamber from the exterior, the capsule being retained in a housing and the seal carrier being removably attached to one of the housing and the capsule, and connecting means for connecting said article to a needleless injector power source wherein the closing means comprises a plug inserted in the seal carrier wherein the closing means comprises a plug inserted in the seal carrier.
  • 2. An article according to claim 1, wherein the seal carrier is frangibly attached to the housing or capsule.
  • 3. An article according to claim 1, wherein the housing is present and is molded onto the capsule.
  • 4. An article according to claim 1, wherein the seal carrier is in the form of a tube.
  • 5. An article according to claim 1, wherein a piston is received within the capsule chamber, the drug being between the piston and the capsule wall through which the capsule orifice extends.
  • 6. An article according to claim 1, comprising an attachment element for enabling said attachment to a needleless injector power source.
  • 7. An article according to claim 6, wherein said attachment element is in the form of a thread.
  • 8. An article according to claim 1, wherein the seal carrier is integral with one out of the housing and the capsule.
  • 9. A filled and sealed drug-containing article for attachment to a needleless injector power source, which comprises a needleless injector capsule defining a chamber having a drug in liquid form therein, the capsule having an orifice through a wall thereof, a seal carrier having a seal in which is formed an orifice communicating with the capsule orifice, the seal being in sealing contact with the capsule wall around the orifice in the capsule wall, and closing means for closing the seal carrier to the exterior whereby to seal off the drug in the chamber from the exterior, the capsule being retained in a housing and the seal carrier being removably attached to one of the housing or the capsule, and connecting means for connecting said article to a needleless injector power source, wherein the seal carrier is frangibly attached to the housing or capsule.
  • 10. An article according to claim 9, wherein the closing means is a plug inserted in the seal orifice.
  • 11. An article according to claim 9, wherein the closing means is provided by a deformed wall portion of the seal carrier.
  • 12. An article according to claim 9, wherein the housing is present and is molded onto the capsule.
  • 13. An article according to claim 9, wherein the seal carrier is in the form of a tube.
  • 14. An article according to claim 9, wherein a piston is received within the capsule chamber, the drug being between the piston and the capsule wall through which the capsule orifice extends.
  • 15. An article according to claim 9, comprising an attachment element for enabling said attachment to a needleless injector power source.
  • 16. An article according to claim 15, wherein said attachment element is in the form of a thread.
  • 17. An article according to claim 9, wherein the seal carrier is integral with one out of the housing of the capsule.
Priority Claims (2)
Number Date Country Kind
9606904 Apr 1996 GB
9608782 Apr 1996 GB
US Referenced Citations (17)
Number Name Date Kind
3729031 Baldwin Apr 1973
3945383 Bennett et al. Mar 1976
4010747 Clark et al. Mar 1977
4227528 Wardlaw Oct 1980
4338980 Schwebel et al. Jul 1982
4351692 Ouellette Sep 1982
4507113 Dunlap Mar 1985
4518385 Lindmayer et al. May 1985
4568346 van Dijk Feb 1986
4662878 Lindmayer May 1987
4898209 Zbed Feb 1990
5062830 Dunlop Nov 1991
5188615 Haber et al. Feb 1993
5256142 Colavecchio Oct 1993
5503627 McKinnon et al. Apr 1996
5879327 DeFarges et al. Mar 1999
5938637 Austin et al. Aug 1999
Foreign Referenced Citations (14)
Number Date Country
0 201 638 Nov 1986 EP
0 328 504 Aug 1989 EP
0 412 621 Feb 1991 EP
0 526 772 Feb 1993 EP
0 737 484 Oct 1996 EP
824357 Feb 1938 FR
206 016 Aug 1990 HU
133435 Nov 1966 NL
WO 9503844 Feb 1995 WO
WO9524176 Sep 1995 WO
WO9615821 May 1996 WO
WO 9628202 Sep 1996 WO
WO 9722375 Jun 1997 WO
WO9812121 Mar 1998 WO